Clinical Trial

NWRD09 for Persistent Cervical HPV16 Infection

Name: NWRD09 for Persistent Cervical HPV16 Infection — clinical trial record (NCT07710703)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind, placebo controlled study to determine the efficacy and safety of NWRD09 in adult women with persistent cervical HPV16 infection.

Trial Details

NCT Number	NCT07710703
Lead Sponsor	Newish Biotech (Wuxi) Co., Ltd.
Conditions	Persistent Cervical HPV16 Infection
Enrollment	60 participants
Start Date	2026-02-10
Primary Completion	2026-11-30 (estimated)
Study Completion	2027-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-17